Vnitřní lékařství 2/2021

HLAVNÍ TÉMA Diagnostika a terapie chronické pankreatitidy dle UEG guidelines | 91 / Vnitř Lék 2021; 67(2): 85–91 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz 7. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995; 332: 1482-1490. 8. Whitcomb DC, Frulloni L, Garg P et al. An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016; 16: 218–224. 9. Bojková M, Dítě P, Kunovský L, et al. The role of metabolic syndrome in the induction of chronic pancreatitis after a first attack of acute pancreatitis -multicenter trial. Vnitř Lék 2020; 66(8): e12–e16. 10. Bertilsson S, Sward P, Kalaitzakis E. Factors that affect disease progression after first attack of acute pancreatitis. Clinical Gastroenterology and Hepatology 2015; 13: 1662–1669. 11. Ahmed Ali U, Issa Y, Hagenaars JC et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol He- patol 2016; 14(5): 738–746. 12. Hoffmeister A, Mayerle J, Beglinger C et al. Definition, aetiology, diagnostic examina- tions, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastro- enterol 2015; 53: 1443–1495. 13. Löhr JM, Dominguez‑Munoz E, Rosendahl J et al. United European Gastroenterology evidence – based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPa- nEU). United European Gastroenterol Journal 2017; 5(2): 153–199. 14. Shmulewitz A, Teefey SA, Robinson BS et al. Factor affecting image quality and dia- gnostic efficacy in abdominal sonography: a prospective study of 140 patients. J Clin Ul- trasound 1993; 21: 623–630. 15. Perez‑Johnston R, Sainani NI, Sahani DV. Imaging of chronic pancreatitis (including gro- ove and autoimmune pancreatitis). Radiol Clin North Am 2012; 50: 447–466. 16. Anderson SW, Sato JA. Pancreatic duct evaluation: accuracy of portal venous phase 64 MDCT. Abdominal Imaging 2009; 34: 55–64. 17. Dimastromatteo J, Brentnall T, Kelly K. Imaging in pancreatic disease Nature Reviews Gastroenterol Hepatol 2017; 14: 97–109. 18. Sandrasegaran K, Lin C, Akisik FM. et al. State – of‑the‑art pancreatic MRI. AJR Am J Roentgenol 2010; 195: 42–53. 19. Kim T, Murakami T, Takamura M et al. Pancreatic mass due to chronic pancreatitis: co- rrelation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 2001; 177(2): 367–371. 20. Catalano MF, Sahai A, Levy M et al. EUS‑based criteria for the diagnosis of chronic pan- creatits. The Rosemont classification. Gastrointest Endosc 2009; 69: 1251–1261. 21. Iglesias‑García J, Lariño‑Noia J, Lindkvist B et al. Endoscopic ultrasound in the diagno- sis of chronic pancreatitis. Rev Esp Enferm Dig 2015; 107(4): 221–228. 22. Shi Y, Glaser KJ, Venkatesh SK et al. Feasibility usinig 3D MR elastography to determi- ne pancreatic stiffness in healthy volunteers. J Magn Reson Imaging. 2015; 41: 369–375. 23. Tirkes T, Lin C, Fogel EL et al. T1 mapping for the diagnosis of mild chronic pancreati- tis. J Magn Reson Imaging. 2017; 45: 1171–1176. 24. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, Lin JA, Rydberg M. Assessment of chronic pancreatitis: utility of diffusion‑weighted MR imaging with secre- tin enhancement. Radiology 2009; 250(1): 103–109. 25. Rebours V, Boutron‑Ruault MC, Schnee M et al. The natural history of hereditary pan- creatitis: a national series. Gut 2009; 58: 97–103. 26. Németh BC, Sahin‑Tóth M. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014; 306: 466–473. 27. Masson E, Chen JM, Scotet V et al. Association of rare chymotrypsinogen C(CTRC) gene variations in patients with idiopathic chronic pancreatitis. Human Genetics 2008; 123: 83–91. 28. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disea- se. Gut 2005; 54Suppl 6: vi1–vi28. 29. Löhr JM. Exocrine pancreatic insufficiency. Uni‑Med Verlag AG 2010. ISBN: 978- 3895992025. 30. Přecechtělová M, Dítě P, Soška V et al. Změny plazmatických hladin vitaminů C a E a volných kyslíkových radikálů u nemocných s chronickou pankreatitidou. Čes a Slov Gas- troent 1994; 48 (2): 47–51. 31. Pezzilli R, Andriulli A, Bassi C et al. Exocrine Pancreatic Insuf ficiency collaborati- ve (EPIc) Group. Exocrine pancreatic insuf ficiency in adults: a shared position state- ment of the Italian Association for the Study of the Pancreas. World J Gastroenterol 2013; 19(44): 7930–7946. 32. Domínguez‑Muñoz JE, Drewes AM, Lindkvist B et al. Recommendations from United European Gastronterology evidence‑based guidelines for diagnosis and therapy of chro- nic pancreatitis. Pancreatology 2018; 18: 847–854. 33. Iglesia D, Avci B, Kiriukova M et al. Pancreatic exocrine insuf ficiency and pancrea- tic enzyme replacement therapy in patients with advanced pancreatic cancer: A sys- tematic review and meta‑analysis. United European Gastroenterol Journal 2020; 8(9): 1115–1125. 34. Chaudhary A, Domínguez‑Muñoz JE, Layer P et al. Pancreatic exocrine insufficiency as a complication of gastrointestinal surgery and the impact of pancreatic enzyme repla- cement therapy. Dig Dis 2020; 38: 53–68. 35. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH‑sensitive enteric coated pancreatic enzyme preparation with conventional pancre- atic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroente- rology 1983; 84: 476–482. 36. Warshaw AL, Banks PA, Fernándéz‑Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998; 115: 765–776. 37. Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol and Ther 2016; 7(3): 370–386. 38. Pitchumoni CS. Chronic pancreatitis: pathogenesis and management of pain. J Clin Gastroenterol 1998; 27: 101–107. 39. Enweluzo C, Tlhabano L. Pain management in chronic pancreatitis: taming the beast. Clin Exp Gastroenterol 2013; 6: 167–171. 40. Talukdar R, Murthy HM, Reddy DN. Role of methionine containing antioxidant com- bination in the management of pain in chronic pancreatitis: a systematic review. Pancre- atology. 2015; 15: 136–144. 41. Winstead NS, Wilcox CM. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis--a review. Pancreatology 2009; 9: 344–350. 42. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983; 28: 97–102. HLEDÁME LÉKAŘE DOORDINACÍ VPL V TĚCHTO LOKALITÁCH: Nabízíme: • odměnu 60 000 Kč čistého měsíčně (mzda při plném úvazku 30 hod/týdně pro lékaře L2) • možnost částečného úvazku, ve volbě pracovní doby • náborový příspěvek ve výši 1 měsíčního platu • placené vzdělávací ak ce do výše až 20tis. ročně • 5 týdnů dovolené, rekreační objekty Vhodné i pro lékaře s atestací z oboru interna, nebo v předatestační přípravě, v případě zájmu zajistíme k ompletní a kvalitní přípravu k atestaci Kontakt: Mgr. K ateřina Nevanová, 773 545 225, personalni@vseobecnyleka r .cz